Laman UtamaMBIO • NASDAQ
add
Mustang Bio Inc
Tutup sebelumnya
$0.77
Julat hari
$0.74 - $0.79
Julat tahun
$0.53 - $7.00
Permodalan pasaran
5.87J USD
Bilangan Purata
38.44K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 670.00K | 2,676.92% |
Pendapatan bersih | -538.00K | 43.49% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | -670.00K | -970.13% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 17.27J | 152.46% |
Jumlah aset | 17.59J | 89.01% |
Jumlah liabiliti | 8.06J | -38.82% |
Jumlah ekuiti | 9.53J | — |
Syer tertunggak | 7.58J | — |
Harga kepada buku | 0.59 | — |
Pulangan pada aset | -9.07% | — |
Pulangan pada modal | -17.36% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -538.00K | 43.49% |
Tunai daripada operasi | -1.72J | 13.97% |
Tunai daripada pelaburan | 0.00 | — |
Tunai daripada pembiayaan | 0.00 | -100.00% |
Perubahan bersih dalam tunai | -1.72J | -158.46% |
Aliran tunai bebas | -1.87J | -21.64% |
Perihal
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Diasaskan
2015
Ibu pejabat
Tapak web
Pekerja
4
